Published in Lab Business Week, April 11th, 2004
The financing was oversubscribed and included new investors Johnson & Johnson Development Corporation, Gund Investment Corporation, and Anthem Capital and existing investors ProQuest Investments and Tullis-Dickerson & Company. BioRexis has raised over $38 million since its inception in July 2002.
As part of the financing, Duane Mason, cofounder and general partner of Prism Venture Partners, will join BioRexis' board of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week